TBTamara L. Blake

Tamara L. Blake

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tamara L. Blake has a total of 131 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lung function trajectories in children with cystic fibrosis aged 3-17 years: impact of elexacaftor-tezacaftor-ivacaftor on lung function

    by Brett P Dyer, Maddy Deery, Rebecca Heyman, Paul D Robinson, Claire E Wainwright, Peter D Sly, Robert S Ware, Tamara L Blake

    Background: Elexacaftor-tezacaftor-ivacaftor (ETI) has been demonstrated to improve lung function in clinical trials; however, evidence describing effects on trajectories and whether long-term improvements are sustained (>1-year) is lacking. We estimated within-person lung clearance index (LCI) trajectories before and after ETI initiation, assessing changes in level and rate of change, alongside acute LCI change, up to three years after ETI initiation. Methods: Prospective observational study of children at a tertiary hospital. Children aged 3–17 years with ≥2 LCI testing occasions (i) before and (ii) after starting ETI were used to describe lung function trajectories. Children with ≥1 pre-ETI and ≥1 post-ETI LCI occasion(s) were used to describe acute LCI change after ETI initiation. Age-adjusted LCI trajectories for time periods (i) before and (ii) after ETI initiation were estimated using linear mixed-effects models, and pre- and post-ETI LCIs were compared using paired Wilcoxon tests. Results: Mean pre-ETI and post-ETI longitudinal changes in LCI were -0.007 (95% CI: -0.28, 0.27; n=35) and 0.12 (95% CI: -0.17, 0.41; n=20) turnovers per year, respectively. Before ETI initiation, 57% (30/53) of patients had an LCI≥7.1 turnovers (indicating impaired lung function), compared to 26% (14/53) post-ETI, with a median LCI difference of -0.70 (95% CI -0.84, -0.46; p<0.001) turnovers. Within-individual variability in LCI decreased post-ETI. Conclusions: Our real-world data within a unique longitudinal study provide a comprehensive picture of ETI benefit by outlining not only acute improvement in LCI but maintained stability in LCI trajectories and improved LCI stability sustained up to three years post-initiation.

  • Top Cited Papers
    Open Access

    Multiple defects in macrophage antibacterial responses support intracellular survival of Mycobacterium abscessus in cystic fibrosis

    by Abdullah A. Tarique, Stefan Emming, Dean Kelk, Jayden Logan, Divya Ramanth, Emma K. Dalton, Kaustav Das Gupta, Tamara Blake, James E. B. Curson, Syeda Farhana Afroz, et al.

    The prevalence of Mycobacterium abscessus (MABS) infections in people with cystic fibrosis (pwCF) is increasing. Macrophages are key phagocytic cells that recognize bacteria via cell surface receptors, engulf them into phagosomes, and then utilize diverse killing strategies. Here, we used human primary monocyte-derived macrophages (MDMs) from healthy controls (HCs) and pwCF to investigate how they processed and killed MABS. Expression of phagocytosis-related pattern recognition receptors (TLR2, Dectin-1, Dectin-2, and MARCO), engulfment of MABS, and lysosomal acidity were all reduced in CF-MDMs. MABS-infected CF-MDMs also had reduced mitochondrial mass, mitochondrial reactive oxygen species (mitoROS) production, relative intracellular zinc levels and inducible mRNA expression of the antibacterial zinc transporters, SLC30A1 and SLC39A8. Stimulation of mitoROS production in HC-MDMs with antimycin A reduced intracellular loads of MABS, confirming that MABS are sensitive to this mechanism of killing and suggesting that the mitoROS defect in MABS-infected CF-MDMs compromises bacterial killing. Accordingly, CF-MDMs failed to control MABS infection, with these cells allowing significantly increased intracellular MABS survival and expansion over 6 d. While treatment with the CFTR modulator, elexacaftor–tezacaftor–ivacaftor (ETI) did increase CFTR channel function and corrected CF macrophage functions to some degree, this was not sufficient to increase MABS killing. Taken together, our findings suggest important roles for functional CFTR in internalization and killing of MABS within macrophages, with CFTR dysfunction supporting MABS survival and replication in macrophages. Under our experimental conditions, ETI treatment failed to fully restore macrophage functions against MABS, highlighting the need for alternative, host-targeted approaches for improving macrophage functions in CF.


  • Open Access

    Oxidative stress as a pathway linking maternal phthalate and bisphenol exposure to childhood allergy and lung function: Mediation and interaction analyses

    by Thomas Boissiere-O'NEill, Nina Lazarevic, Anne-Louise Ponsonby, Peter D. Sly, Aimin Chen, Tamara L. Blake, Cassidy Du Berry, Louise King, Cindy Pham, Samuel Tanner, et al.

  • A Culturally Responsive Indigenous Health Worker Spirometry Training and Mentoring Programme (IHWS) Increases Quantity and Quality of Spirometry Performed in Primary Care

    by Leanne Rodwell, Irene Schneider, Anne Bernard, Tamara Blake, Patsi Mawn, Deearne Dodd, Jeleacha Hopkins‐Lincolne, Margaret S. McElrea

    Objective: Evaluate the impact on spirometry quality of a culturally responsive Indigenous Health Worker Spirometry Training and Mentoring programme (IHWS). Methods: Participation in two‐day face‐to‐face IHWS including post‐training telehealth mentoring Design: Submission of spirometry reports before training (T1), after training (T2) and after telehealth mentoring (T3). Setting: Urban, rural and remote primary healthcare services in Queensland Australia. Participants: Primarily Australian First‐Nations Health Workers. Main Outcome Measures: Two raters used nine‐point quality criteria to score spirometry at T1, T2 and T3. Inter‐rater reliability was assessed using Cohen's original kappa. Reports submitted at a minimum of two time‐points were included in the analysis. A linear mixed model analysis and post hoc analysis assessed differences in total scores across different timepoints. Results: Between 2011 and 2018, 360 participants (75.5% Indigenous) attended 43 workshops. Of the 284 participants attending workshops #1–#34, 56.7% (161/284) hadn't performed spirometry before IHWS and were excluded from comparative analysis because spirometry reports could be submitted at only one timepoint (T2). Introduction of telehealth mentoring sessions from workshop #35, increased spirometry submission for assessment at T2 from 9.9% (28/284) to 68.4% (52/76). Thirty‐six participants submitted reports at two timepoints or more. Spirometry quality improved across all timepoints ( p < 0.001). Inter‐rater reliability was good or very good (0.83–0.91). Conclusion: Two‐day F2F culturally responsive IHWS training increases the quality of spirometry testing. Further increases in quality occur after telehealth mentoring. This model could be adapted to teach spirometry to First‐Nation's health workers of other nations.


  • Open Access

    Phthalates, Bisphenols, and Childhood Allergic Phenotypes: Findings from Two Birth Cohort Studies

    by Thomas Boissiere-O’neill, Nina Lazarevic, Anne-Louise Ponsonby, Peter D. Sly, Aimin Chen, Tamara L. Blake, Jeffrey R. Brook, Cassidy Du Berry, Louise King, Piushkumar J. Mandhane, et al.

    Background Phthalates and bisphenols may disrupt early immune development, but their impact on allergies and lung function remains uncertain. We investigated associations between prenatal and postnatal exposure to these chemicals, allergies, and lung function in preschool children, focusing on atopic and non-atopic phenotypes. Methods We used data from the Barwon Infant Study (BIS) and the Canadian Healthy Infant Longitudinal Development Study (CHILD). Urinary metabolites were measured at 36 weeks gestation (BIS) and from three to 36 months postnatally (CHILD). Atopy was assessed via skin prick tests at 4-5 years. Oral food challenge was assessed at one year (BIS). Outcomes included asthma, wheeze, eczema, and rhinitis at 4-5 years. Phenotypes were defined by atopic and outcome status. Lung function at 4-5 years was assessed using multiple-breath washout and oscillometry. We used generalised linear models for single compounds, and quantile G-computation and Bayesian kernel machine regression for exposure mixtures. Results Exposure mixtures showed a positive association with asthma. Postnatal phthalate mixtures were associated with higher airway resistance and lower reactance. Prenatal exposure mixtures (odds ratio [OR] = 2.24; 95% confidence interval [CI]: 1.03-4.85), as well as postnatal diethyl (OR = 1.50; 95% CI: 1.10-2.04), dibutyl (OR = 1.71; 95% CI: 1.10-2.68) and butyl-benzyl (OR = 1.33; 95% CI: 1.01-1.77) phthalates, were associated with non-atopic asthma. Conversely, prenatal mixtures showed inverse associations with eczema and food allergy. Conclusion Phthalates may predispose pre-school children to non-atopic asthma but not atopic outcomes. Future studies are needed to confirm these associations. HIGHLIGHTS Pre- and postnatal phthalates were associated with non-atopic asthma in children. Phthalates and bisphenols were not associated with atopic outcomes. Postnatal phthalates were associated with reduced lung function in children.

  • Mental health, behaviour and sleep quality in children 6–11 years before and after elexacaftor/tezacaftor/ivacaftor initiation

    by Tonia Douglas, Maddison Deery, Hayley Kimball, Vanessa E. Cobham, Sophia Panochini, Paul D Robinson, Claire E Wainwright, Peter D Sly, Tamara Blake


  • Open Access

    Deformation-aware GAN for Medical Image Synthesis with Substantially Misaligned Pairs

    by Bowen Xin, Tony Young, Claire E Wainwright, Tamara Blake, Leo Lebrat, Thomas Gaass, Thomas Benkert, Alto Stemmer, David Coman, Jason Dowling

    Medical image synthesis generates additional imaging modalities that are costly, invasive or harmful to acquire, which helps to facilitate the clinical workflow. When training pairs are substantially misaligned (e.g., lung MRI-CT pairs with respiratory motion), accurate image synthesis remains a critical challenge. Recent works explored the directional registration module to adjust misalignment in generative adversarial networks (GANs); however, substantial misalignment will lead to 1) suboptimal data mapping caused by correspondence ambiguity, and 2) degraded image fidelity caused by morphology influence on discriminators. To address the challenges, we propose a novel Deformation-aware GAN (DA-GAN) to dynamically correct the misalignment during the image synthesis based on multi-objective inverse consistency. Specifically, in the generative process, three levels of inverse consistency cohesively optimise symmetric registration and image generation for improved correspondence. In the adversarial process, to further improve image fidelity under misalignment, we design deformation-aware discriminators to disentangle the mismatched spatial morphology from the judgement of image fidelity. Experimental results show that DA-GAN achieved superior performance on a public dataset with simulated misalignments and a real-world lung MRI-CT dataset with respiratory motion misalignment. The results indicate the potential for a wide range of medical image synthesis tasks such as radiotherapy planning.


  • Open Access

    Association of Maternal Air Pollution Exposure and Infant Lung Function Is Modified by Genetic Propensity to Oxidative Stress

    by Dwan Vilcins, Wen Ray Lee, Cindy Pham, Sam Tanner, Luke D. Knibbs, David Burgner, Tamara L. Blake, Toby Mansell, Anne-Louise Ponsonby, Peter D. Sly, et al.

    Background and objective: The association between air pollution and poor respiratory health outcomes is well established. Children are particularly at risk from air pollution, especially during the prenatal period as their organs and systems are still undergoing crucial development. This study investigated maternal exposure to air pollution during pregnancy and oxidative stress (OS), inflammation, and infant lung function at 4 weeks of age. Methods: Data from the Barwon Infant Study were available for 314 infants. The exposure to NO2 and PM2.5 were estimated. Infant lung function (4 weeks) was measured by multiple-breath washout. Glycoprotein acetyls (GlycA) (36 weeks prenatal), cord blood, and OS biomarkers were measured in maternal urine (28 weeks). A genetic pathway score for OS (gPFSox) was calculated. Linear regression was used and potential modification by the OS genotype was tested. Results: There was no relationship between maternal exposure to air pollution and infant lung function, or with GlycA or OS during pregnancy. We found an association in children with a genetic propensity to OS between NO2 and a lower functional residual capacity (FRC) (β = −5.3 mls, 95% CI (−9.3, −1.3), p = 0.01) and lung clearance index (LCI) score (β = 0.46 turnovers, (95% CI 0.10, 0.82), p = 0.01). Conclusion: High prenatal exposure to ambient NO2 is associated with a lower FRC and a higher LCI score in infants with a genetic propensity to oxidative stress. There was no relationship between maternal exposure to air pollution with maternal and cord blood inflammation or OS biomarkers.


  • Open Access

    Changes in urinary glutathione sulfonamide (GSA) levels between admission and discharge of patients with cystic fibrosis

    by Tamara L Blake, Peter D Sly, Isabella Andersen, Claire E Wainwright, David W Reid, Scott C Bell, Briana R Smith, Anthony J Kettle, Nina Dickerhof